Polymorphism of TPH2 gene rs120074175 is not associated with risk factors of schizophrenia | Zendy

MelisaI Barliana | Zendy; JamesP Laksono | Zendy; Riyadi Sumirtanurdin | Zendy; Haafizah Dania | Zendy; FitriN Ramadhani | Zendy; DyahA Perwitasari | Zendy; Rizky Abdulah | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Polymorphism of TPH2 gene rs120074175 is not associated with risk factors of schizophrenia

Author(s) -

MelisaI Barliana,

JamesP Laksono,

Riyadi Sumirtanurdin,

Haafizah Dania,

FitriN Ramadhani,

DyahA Perwitasari,

Rizky Abdulah

Publication year - 2019

Publication title -

journal of pharmacy and bioallied sciences

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.268

H-Index - 36

eISSN - 0976-4879

pISSN - 0975-7406

DOI - 10.4103/jpbs.jpbs_216_19

Subject(s) - tph2 , ethidium bromide , tryptophan hydroxylase , genotype , schizophrenia (object oriented programming) , allele , genetics , medicine , gene , serotonin , psychiatry , biology , dna , receptor , serotonergic

Polymorphism on tryptophan hydroxylase 2 ( TPH2 ) gene rs120074175 can cause the synthesis of neurotransmitter serotonin in the brain to reduce up to 80%. Reduced serotonin in the brain can cause dopamine release to occur continuously. Excess dopamine in the brain may cause positive symptom of schizophrenia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research